Aberrant DNA methylation in chronic myeloid leukemia: cell fate control, prognosis, and therapeutic response

MM Behzad, S Shahrabi, K Jaseb, J Bertacchini… - Biochemical …, 2018 - Springer
Chronic myeloid leukemia (CML) is a hematopoietic stem cell malignancy characterized by
the expression of the BCR–ABL1 fusion gene with different chimeric transcripts. Despite the …
被引用次数：19 相关文章

Aberrant DNA Methylation in Chronic Myeloid Leukemia: Cell Fate Control, Prognosis, and Therapeutic Response

MM Behzad, S Shahrabi, K Jaseb… - Biochemical …, 2018 - pubmed.ncbi.nlm.nih.gov
Chronic myeloid leukemia (CML) is a hematopoietic stem cell malignancy characterized by
the expression of the BCR-ABL1 fusion gene with different chimeric transcripts. Despite the …

Aberrant DNA Methylation in Chronic Myeloid Leukemia: Cell Fate Control, Prognosis, and Therapeutic Response.

MM Behzad, S Shahrabi, K Jaseb… - Biochemical …, 2018 - europepmc.org
Chronic myeloid leukemia (CML) is a hematopoietic stem cell malignancy characterized by
the expression of the BCR-ABL1 fusion gene with different chimeric transcripts. Despite the …

Aberrant DNA Methylation in Chronic Myeloid Leukemia: Cell Fate Control, Prognosis, and Therapeutic Response

MM Behzad, S Shahrabi, K Jaseb… - Biochemical …, 2018 - search.proquest.com
Chronic myeloid leukemia (CML) is a hematopoietic stem cell malignancy characterized by
the expression of the BCR–ABL1 fusion gene with different chimeric transcripts. Despite the …

Aberrant DNA Methylation in Chronic Myeloid Leukemia: Cell Fate Control, Prognosis, and Therapeutic Response

MM Behzad, S Shahrabi, K Jaseb… - BIOCHEMICAL …, 2018 - iris.unimore.it
Chronic myeloid leukemia (CML) is a hematopoietic stem cell malignancy characterized by
the expression of the BCR-ABL1 fusion gene with different chimeric transcripts. Despite the …

Aberrant DNA Methylation in Chronic Myeloid Leukemia: Cell Fate Control, Prognosis, and Therapeutic Response.

MM Behzad, S Shahrabi, K Jaseb… - Biochemical …, 2018 - search.ebscohost.com
Chronic myeloid leukemia (CML) is a hematopoietic stem cell malignancy characterized by
the expression of the BCR-ABL1 fusion gene with different chimeric transcripts. Despite the …

[引用][C] Aberrant DNA Methylation in Chronic Myeloid Leukemia: Cell Fate Control, Prognosis, and Therapeutic Response

MM Behzad, S Shahrabi, K Jaseb, J Bertacchini… - 2018